Is a Bioceramic Glass Bone Graft Superior to Spongious Allografts in Femoral and Tibial Benign Bone Lesions?

Objective: this study aimed to examine the results of spongious and bioceramic bone graft applications in benign lesions of the lower extremity long bones.
Methods: Forty-seven patients, who applied to our hospital between the years 2007 and 2013; who received curettage-grafting for benign bone lesions in the long bones carrying lower extremity weight were examined retrospectively.
Results: In the bioceramic glass bone graft group, an increased average consolidation ratio, which is statistically significant compared to the spongious allograft group (p=0.002), was observed. When the fibrous dysplasia patients were considered a subgroup, the consolidation ratio in the bioceramic glass bone graft group was found to be significantly high compared to the spongious allograft group (p=0.029).
Conclusion: Bioceramic glass bone grafts are bone filler materials that hold radiologically superior and clinically similar results compared to spongious allografts. Having a statistically significant radiological consolidation success in fibrous dysplasia, which is a benign aggressive tumor, bioceramic glass bone grafts may be thought to be capable of being an advantage option for benign aggressive tumors.